Joseph Belanoff is Chief Executive Officer and President of Corcept Therapeutics Inc (CORT). The company reported total compensation of $15,303,551 for fiscal year 2025.
| Salary | $1,182,333 |
|---|---|
| Bonus | $1,190,000 |
| Stock awards | $0 |
| Option awards | $12,907,718 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $23,500 |
| Total | $15,303,551 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Corcept Therapeutics Inc filed April 17, 2026, accession 0001628280-26-025735.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joseph Belanoff this page | Chief Executive Officer and President | $15,303,551 |
| Charles Robb | Chief Business Officer and Secretary | $6,380,500 |
| William Guyer | Chief Development Officer | $6,340,445 |
| Sean Maduck | President, Corcept Endocrinology | $6,208,642 |
| Atabak Mokari | Chief Financial Officer and Treasurer | $6,135,667 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Corcept Therapeutics Inc compensation brief.
Joseph Belanoff's compensation sits inside Corcept Therapeutics Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.